Enan­ta sues Pfiz­er, de­mand­ing com­pen­sa­tion for Paxlovid-re­lat­ed patent in­fringe­ment

Pfiz­er is see­ing an uptick in lit­i­ga­tion re­lat­ed to its mega-block­buster Covid-19 vac­cine and ther­a­peu­tic, with the lat­est suit com­ing from Mass­a­chu­setts-based Enan­ta Phar­ma­ceu­ti­cals. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER